Please login to the form below

Not currently logged in
Email:
Password:

business model

This page shows the latest business model news and features for those working in and with pharma, biotech and healthcare.

Bayer's drop of the future

Bayer's drop of the future

Flipping through the pages of ‘Darwin’s Medicine’, I am reminded that I saw – and see – the challenge of business model design as one of capability acquisition. ... And in Bayer/One Drop we see a holobiont business model designed to bring

Latest news

  • Not your average training programme: why does allegro work so well? Not your average training programme: why does allegro work so well?

    So, how and why is the programme so successful? A tried and tested model. ... Not only that, this model ensures that the business is protected from a resource perspective, with ‘home-grown’ talent building long-term careers with Ashfield Healthcare

  • Stop that! Stop that!

    My ‘x plus y causes z’ mental model, shaped by a physical sciences education, was that some factors, like the genomic revolution and globalisation, would lead to a new business model ... Instead, it showed an explosion of many business models and,

  • BioNTech bolsters COVID-19 vaccine capacity with Novartis deal BioNTech bolsters COVID-19 vaccine capacity with Novartis deal

    From a strategic standpoint, the new site will bolster our vertically integrated business model with in-house manufacturing capabilities for mRNA manufacturing as well as vaccine formulation,” he added.

  • Trust – years to build, seconds to break and forever to repair Trust – years to build, seconds to break and forever to repair

    These are being viewed by the public at record levels. Having an understanding of the complexity of drug development is one of the fundamentals in establishing trust in how our business ... model works and in supporting discussions around IP, access,

  • Awesome abstraction Awesome abstraction

    Business development deals and commercial operating models show the power of Generalised Darwinism. ... So, there is no single model. Instead, a little like the business development example, we are beginning to see a speciation in commercial models

More from news
Approximately 1 fully matching, plus 238 partially matching documents found.

Latest Intelligence

  • Sourcing R&D innovation: why pharma companies need to evolve their business models Sourcing R&D innovation: why pharma companies need to evolve their business models

    Such developments are also expected to improve the efficiency of research and discovery, catapulting the current R&D business model into an era of increased productivity and improved economics. ... It is likely that no single approach or business model

  • Driving the innovation engine Driving the innovation engine

    Routine’ innovation builds on a company’s existing technological competences and fits with its existing business model and customer base. ... The boundary is that it’s limited to the stakeholders – including, for instance, the venture capital

  • Darwinian leadership in the life sciences industry Darwinian leadership in the life sciences industry

    There is hardly an idea or a human activity that has not be held up by some author or other as the model for leadership in business. ... Even compared to other capital-intensive businesses, pharma and medtech is an exceptionally risky business.

  • Vertex: a vision of treating all CF patients worldwide draws closer Vertex: a vision of treating all CF patients worldwide draws closer

    This certainly looks like a very healthy business, but as Jeff Leiden was at pains to point out to the recent health select committee hearing in London, the company has made ... However, as in other disease areas, it threatens to upend the biopharma

  • The Orkambi blame game The Orkambi blame game

    were ‘freeloading’ while high US prices provide the incentive for the industry’s R&D-based business model. ... Vertex, at £850m a year, would go out of business in three to five years.

More from intelligence
Approximately 0 fully matching, plus 46 partially matching documents found.

Latest appointments

  • Neurocentrx appoints two members to the board Neurocentrx appoints two members to the board

    Brooksby brings experience in business and growth strategy across the healthcare sector having held senior global positions at Pfizer, Sanofi and Wellcome - now GSK. ... Brooksby said: “My focus is to accelerate the business model and drive commercial

  • Rainer Boehm and Hervé Hoppenot join Cellectics board Rainer Boehm and Hervé Hoppenot join Cellectics board

    Boehm spent 29 years serving Novartis working in various senior management, marketing, sales, and medical affairs roles, and his expertise spans from leadership and development to business model solutions. ... oncology and head of the US oncology

  • Novocure’s chief commercial officer to step down Novocure’s chief commercial officer to step down

    During his tenure, Peter developed our commercial business model, launched the Optune brand and drove eight consecutive quarters of active patient and revenue growth after the presentation of our EF-14

  • Galenica Group strengthens management team Galenica Group strengthens management team

    We opted for these variant because of the excellent knowledge Stefan Schulze brings to further developing the business model of Vifor Pharma.”. ... Santé. Burkhard joined the Galenica Group in 1996 as corporate controller of Galenica, taking

  • Moderna Therapeutics appoints chief business officer Moderna Therapeutics appoints chief business officer

    Saqib Islam brings experience from Alexion Pharmaceuticals. Cambridge, Massachusetts-based Moderna Therapeutics has appointed Saqib Islam as its new chief business officer from 9 May. ... Islam said: “Already a clinical stage company, Moderna has

More from appointments
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 21 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...

Infographics